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Abstract 
 
Background. Clinical nerve conduction studies (NCS) are often used as a secondary outcome measure 
in therapeutic trials, but show a high degree of inter-trial variability even when technical factors 
known to affect the recorded responses are minimised. This raises the intriguing possibility that some 
of the observed variability may reflect true changes in nerve activity.  
Objectives. Our aim was determine how much variability these factors might produce, and how this 
might affect the results of commonly used neuropathy rating scales. 
Methods. A standardised protocol was repeated over forty consecutive trials by the same operators in 
two healthy subjects. The protocol included recordings that shared either a stimulating or a recording 
electrode position, such that changes due to electrode position could be excluded, and hand 
temperature was closely controlled. 
Results. Despite controlling for inter-operator differences, electrode position, and hand temperature, 
the variability in sensory nerve action potential (SNAP) amplitude was extremely high (Range 23µV, 
CoV=10.7-18.8). This variability was greater than the change in amplitude needed to move a subject 
from point 0 to point 4 on the CMT neuropathy rating scale. Neither temperature or electrode position 
accounted for all of this variability, suggesting that additional as yet unidentified factors are 
responsible. 
Conclusion. Even under closely controlled conditions and sophisticated laboratory methods, test-to-
test variability can be significant. The factors responsible for this variability may be difficult to 
control, limiting the utility of single nerve recordings as a trial outcome measure.  
 
 
Keywords: nerve conduction studies; reproducibility; serial measurements; technical variability; 
nerve excitability. 
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Abbreviations  
 
ABP = Abductor Pollicis Brevis 
CMAP = compound motor action potential 
CoV = co-efficient of variance  
EMG = electromyography 
ICC = intraclass correlation coefficients 
MedCMAPamp = median CMAP amplitude 
MedCV = median nerve motor forearm velocity 
MedDig1AMP = median digit 1 SNAP amplitude  
MedDig1CV= median digit 1 SNAP conduction velocity 
MedDig3AMP = median digit 3 SNAP amplitude 
MedDig3CV = median digit 3 SNAP conduction velocity 
MedFwmin = median nerve minimum F-wave latency  
NCS = nerve conduction studies 
O = operator 
RadDig1AMP = radial digit 1 SNAP amplitude 
RadDig1CV = radial digit 1 SNAP conduction velocity 
S = subject 
SD = standard deviation 
SNAP = sensory nerve action potential 
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Introduction 
 
Nerve conduction studies (NCS) are widely regarded as an objective, quantitative and reproducible 
evaluation of peripheral nerve function [1] and are widely used in the diagnosis of neuropathies,[2] 
in the serial monitoring of neuropathic disease progression,[3] and in the assessment of therapeutic 
intervention efficacy[4]. Several commonly used neuropathy rating scales include measures of 
motor and sensory response amplitudes as an outcome measure[5].  
In order for a test to be of use in the long term monitoring of any condition, changes in the results 
that it generates must be secondary to changes in the underlying pathology, rather than variability 
inherent to the test itself. However, several of the routinely measured NCS parameters show a high 
degree of variability over serial measurements [6-9] even when potential technical confounds are 
minimised. There are two possible explanations for this residual variability; first, the known 
technical confounds such as hand temperature [10] , hand position [11], and electrode position [12-
15] produce so much inter-trial variability that it is inherently impossible to control for them 
completely no matter how carefully the tests are performed. Second, and more intriguing, is that 
some of the residual variability is not due to technical factors but represent an inherent variability in 
some physiological parameter such as nerve excitability that affects the recorded responses.  
Several factors are known to affect nerve excitability. Some, eg the degree of myelination or depth 
below the skin are specific to a given nerve and are unlikely to change over the duration of a typical 
clinical trial. Others, such as extracellular ion concentration, hormone levels or skin conductances 
do change on a day-to-day basis, and critically all are likely to affect all of the nerves in a given 
body region. Hence, one prediction is that if changes in nerve excitability account for some of the 
variability in NCS values, this variability should affect all of the nerves in tandem. However, if all 
of the variability is due to technical factors such as electrode placement, these will vary 
independently between nerves.  
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We present the first study longitudinal study of multiple commonly tested NCS parameters. This 
was designed such that hand temperature was tightly controlled and two of the measured nerves 
shared a stimulating electrode position, and two shared a recording electrode position. This allowed 
us to construct a model to determine how much of the variability was due to known sources of 
variability and how much remained unexplained. We found that even controlling for all known 
sources of error, the inherent variability of standard NCS parameters was sufficient to cause large 
changes in the scores of commonly used neuropathy rating scales. 
 
 
Materials and methods 
 
Subjects 
The study was conducted by two healthy right-handed physicians (AK, a woman aged 29, 
height 165 cm; and GL, a man aged 30, height 178 cm); both were training at the Department of 
Neurophysiology of the Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom. This pair 
performed 40 trials on each other over a period of 113 days ie a total of 80 trials. When acting as a 
subject these individuals were labelled as S:I and S:II respectively, and when acting as the operator 
were designated as O:I and O:II respectively. In order to validate the technique of these relatively 
inexperienced operators, an experienced consultant clinical neurophysiologist (RW) performed the 
same study protocol on both of these subjects every fifth trial (labelled as O:III) but was not a subject. 
Neither of the subjects had: any history of hand or upper extremity symptoms; any history of recent 
or remote trauma; any systemic and central or peripheral neurological diseases; and were of normal 
body mass index (to limit the influence of physiological variables on the measurements). Both 
subjects participated after giving written informed consent and all the procedure were performed in 
accord with the Helsinki Declaration of 1975. 
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Procedure 
A total of nine commonly performed NCS measurements were recorded in each of the 80 
trials; details of the nerve conduction methodology is given in the supplementary information. The 
entire protocol was performed by the same operators on each other, in the same lab and with the same 
instruments each day at approximately the same time. Room temperature was controlled by a climate 
control system and was monitored and kept at 30 °C during the whole procedure in order to minimize 
skin sympathetic reflex activity [16,17]. The skin temperature in the centre of both hands was 
measured every trial; if <30 °C, hands were warmed in hot water and the temperature rechecked. 
During the procedure, hand temperature was checked periodically to ensure it was stably >30 °C 
(mean hand temperature over the whole procedure was approximately 32 °C). The hand position was 
kept supinated on a couch with fingers slightly spread in a similar position for all recording 
configurations. Although the cutaneous impedance was not measured, the skin was carefully cleaned 
with alcohol solution and dried if wet. Electrode pads and ring electrodes were soaked for one minute 
in physiological saline.  
 
Analysis 
Descriptive statistics, including numbers and percentages of categorical data, or mean, 
standard deviation and coefficient of variation of numerical data were used to characterize the study 
sample. The comparison between frequency data was tested by the Fisher exact test. Agreement 
between the two observers (AK & GL) was estimated using calculations of the intraclass correlation 
coefficients (ICC). Values of ICC below 0.4 were considered poor, values between 0.4 and 0.75 fair 
to good, and values ≥ 0.75 were considered as excellent agreement [18]. We used control charts to 
monitor statistical stability of repeated NCS measurements in longitudinal design. We applied the 
six-sigma rule to detect outliers. After detecting and removing outliers for every serial measurement, 
for both subjects and both sides, we conducted multilevel modelling with NCS data as dependent 
variables, and skin temperature as an independent variable. Multilevel model was performed with a 
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two-level data structure, with serial measurements on the right or the left side at the first level, and 
subjects (S:I or S:II) at the second level. We used a two-sided p value ≤ 0.05 to indicate statistical 
significance. Statistical analyses were performed using R language and environment for statistical 
computing (R Core Team, 2014) [19] and SPSS for Windows, version 21. 
 
 
Results 
 
1) The NCS tests were being performed to a high technical standard. 
We wanted to assess the variability of NCS indices when as far as possible technical factor had been 
removed. Although a standardised protocol was used, it was essential to ensure that all the operators 
were performing the tests to an equal standard. The operators included two relatively inexperienced 
registrars (O:I and O:II) and one experienced consultant (O:III). During the study period O:III (RW) 
performed 504 measurements on S:I (AK) and S:II (GL). Observers I (AK) and II (GL) performed 
1511 measurements on each other. Poor technique leads to measurement errors, and consequently is 
expected to increase the number of outliers. In order to ensure that all three operators were performing 
to an acceptable technical standard, the number of outlying measurements was compared. Observer 
III had 8 (1.6%) outlier measurements, and observer I and II 27 (1.8%) outliers, together. The number 
of outliers showed no statistically significant difference (p = 0.85; Fisher exact test), indicating a 
similar number of errors between the experienced (O:3) and relatively inexperienced operators (O:1 
and O:2).  
 
2) The variability differs between parameters and is comparable to previously published data. Having 
established that all 3 operators were performing the tests to a comparable standard, we compared the 
variability of each of the 9 indices (table 1). For this we used the data from O:1 and O:2 since they 
performed by far the most trials. In keeping with previously published literature, different indices 
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showed different degrees of variability. The lowest co-efficient of variance was seen for the F-wave 
minimum latency (CoV 1.8). Sensory nerve action potential amplitudes (median-digit 1, median-digit 
3, radial-digit 1) showed the highest co-efficient of variation (CoV 10.7-18.8) indicating the least 
stable parameters. Among these, the radial nerve showed the highest variation (range 17 to 40µV; 
CoV 15.6-18.8) over the 80 trials. Summating the SNAP amplitudes from the 3 different nerves 
produced a far lower variability (CoV 8.5). 
 
3) Recording electrode position accounts for some but not all of the amplitude variability. 
We established that the operators in this study were performing the tests to a high technical standard, 
and yet were still producing results with a high variability over time, particularly in recordings of 
SNAP amplitudes. We next investigated the mechanism of the residual variability. We had designed 
the study to incorporate two pairs of measurements that shared either a recording (Median-digit 3 
SNAP vs median-digit 1 SNAP) or a stimulating (median-digit 1 SNAP vs radial-digit 1 SNAP) 
electrode position, and one pair that shared neither (median-digit 3 SNAP vs radial-digit 1 SNAP). 
We selected these pairs since they show among the highest amplitude variability of all commonly 
recorded nerves in published studies, a finding that we replicated. We compared the correlation co-
efficient of the amplitude measurements for these three pairs of recordings (table 2). The correlation 
co-efficient of the amplitudes was highest in the pair that shared a recording electrode position (0.36), 
but was very low for those that shared a stimulating electrode position (0.003) or did not share either 
position (0.04).  
 
4) Temperature accounts for up to half of the variability in sensory nerve conduction velocity but 
does not account for the variability in SNAP amplitude. 
We had taken great care to perform the studies at approximately the same time of day in the same 
temperature controlled room. Furthermore, the skin temperature of both hands was measured both 
before and during the trials to ensure that it remained above 30° C. Nevertheless, these factors remain 
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as potential confounds. No significant differences were seen in the mean or standard deviations of 
these parameters between subjects S:1 and S:2. We therefore felt confident in pooling the data from 
these subjects to develop a linear mixed model using skin temperature as an independent variable and 
the nerve conduction parameters as dependent variables (table 3). This demonstrated significant 
correlations between skin temperature and all of the sensory nerve conduction velocities, explaining 
between 40.3% and 48.4% of the variance. A weaker correlation was found between skin temperature 
an F-wave minimum latency, explaining 18.6% of the variance. However, skin temperature did not 
significantly affect SNAP amplitudes or the median motor conduction velocity.  
 
 
Discussion 
 
We present the first longitudinal study of the variability of multiple nerve conduction indices, and 
exploit the measurement of multiple indices at each trial in an attempt to identify which factors 
account for this variability in the clinical setting.  
The most salient outcome of this study is that even when technically proficient operators use a 
standardised protocol in which known sources of variability have been optimised (to a far greater 
extent than would be achieved during a routine clinical or research study), a large variability in 
individual indices remains. In general, the greatest variability was seen in SNAP amplitudes, with the 
lowest variability seen in F-wave latencies. This has obvious implications for the use of nerve 
conduction studies for serial studies, for example in assessing disease progression or therapeutic 
intervention. The CMT Neuropathy Score gives a value of between 0 and 4 based on the radial SNAP 
amplitude. Whether a patient scores 0 or 4 requires a change in amplitude of only 15µV, significantly 
less than the 23µV variation in this parameter encountered in our study. Indeed, this parameter 
showed the greatest variation in any of the recorded responses, questioning the suitability of using it 
in isolation to monitor progression. We did find that a composite outcome derived from the sum of 
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all 3 nerves produced a far lower variability, and it may be that in future rating scales a score based 
on the sum of several indices will be needed to provide an objective measure of progression.  
We next attempted to determine which factors accounted for this variability, and specifically whether 
it could be accounted for by technical or biological factors. We found that nerves that shared a 
recording electrode position showed a far higher correlation co-efficient in SNAP amplitudes than 
those that did not, indicating that despite attempting to optimise recording electrode position at each 
trial at least some of the remaining variability was due to this factor. This correlation remained only 
moderate, so clearly other factors also influence the variability. Despite controlling the hand 
temperature to a far greater degree than would occur during routine clinical testing, this factor 
accounted for a significant part of the variability in SNAP conduction velocities, but did not account 
for the variability in SNAP amplitude. Since we had also controlled for operator- and equipment-
related errors, this leaves the intriguing possibility that this residual variability reflected an underlying 
change in nerve excitability. We found that there was essentially no correlation in SNAP amplitudes 
between anatomically distant nerves implying that if the remaining variability is due to biological 
factors, these are specific to an individual nerve rather than a general alteration in nerve excitability. 
What these factors might be are an interesting avenue for further study. 
The lack of an independent rater evaluating each curve represents a limitation of the study; similarly, 
although the statistical analysis was refined, it included two subjects only. Although not investigated 
in the present paper, previous studies comparing antidromic and orthodromic techniques found no 
significant difference except for the SNAP amplitude that was bigger and wider in the antidromic 
technique compared to the orthodromic [20]. Finally, other measurements of disease progression, 
such as the maximal isometric voluntary contraction, were not included because they were beyond 
the scope of this study. However, a previous study revealed substantial reproducibility of the 
neurophysiological and myometric measurements in the ulnar nerve-abductor digiti minimi system 
[21]. 
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In conclusion, we believe that nerve conduction studies can still play a role in monitoring disease 
progression, but that the current practice of using single nerve conduction indices may give a false 
impression of objectivity. Even under the most tightly controlled conditions, the variability in single 
nerve indices seems to be too high to be a meaningful indicator of disease progression. Only by using 
composite measures based on recordings from multiple nerves does the consistency needed to 
accurately monitor disease progression appear, and we recommend that any future scales take this 
into account. 
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Table 1. Descriptive statistics of individual nerve conduction indices. Mean, standard deviation (SD) 
and co-efficient of variance (CoV) for all 9 nerve conduction studies parameters are shown for each 
subject and for each side (right and left). 
 
MedDig3AMP = median sensory nerve action potential amplitude from digit 3 (µV); MedDig3CV = 
median-digit 3 sensory nerve action potential conduction velocity (m/s); MedDig1AMP = median 
sensory nerve action potential amplitude from digit 1 (µV); MedDig1CV= median-digit 1 sensory 
nerve action potential conduction velocity (m/s); RadDig1AMP = radial sensory nerve action 
potential amplitude from digit 1 (µV); RadDig1CV = radial-digit 1 sensory nerve action potential 
conduction velocity (m/s); MedCMAPamp = median compound motor action potential amplitude 
(mV); MedCV = median nerve motor forearm velocity (m/s);  MedFwmin =  median nerve minimum 
F-wave latency (ms).  
 
Subject 1   Subject 2  
right left right left 
Site mean ± SD CoV mean ± SD CoV mean ± SD CoV mean ± SD CoV 
MedDig3AMP 51.12 ± 7.8 15.3 41.54 ± 4.817 11.6 58.14 ± 6.884 11.8 42.02 ± 5.633 13.4 
MedDig3CV 54.33 ± 2.297 4.2 56.47 ± 1.793 3.2 58.9 ± 2.425 4.1 63.46 ± 3.122 4.9 
MedDig1AMP 51.30 ± 5.471 10.7 51.61 ± 8.345 16.2 57.48 ± 6.504 11.3 55.5 ± 6.349 11.4 
MedDig1CV 52.580 ± 2.5 4.8 53.429 ± 2.62 4.9 58.733 ± 3.357 5.7 56.267 ± 2.70 4.8 
RadDig1AMP 25.10 ± 4.352 17.3 27.0 ± 5.07 18.8 28.6 ± 4.94 17.3 24.52 ± 3.833 15.6 
RadDig1CV 56.70 ± 2.784 4.9 56.45 ± 2.582 4.6 62.88 ± 2.547 4.1 60.73 ± 2.723 4.5 
MedCMAPamp 24.98 ± 3.01 12.0 23.715 ± 2.711 11.4 26.717 ± 2.937 11.0 24.724 ± 3.044 12.3 
MedCV 58.812 ± 3.16 5.4 58.96 ± 2.566 4.4 58.376 ± 2.032 3.5 56.056 ± 1.878 3.4 
MedFwmin 24.293 ± 0.277 1.1 24.185 ± 0.44 1.8 27.141 ±0.492 1.8 27.439 ± 0.418 1.5 
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Table 2. Correlation matrix showing correlation between SNAP amplitudes from pairs of recording 
/ stimulating electrode positions.  
 
Site MedDig3AMP MedDig1AMP 
MedDig3AMP   
MedDig1AMP 0.36  
RadDig1AMP 0.04 0.003 
 
MedDig3AMP = median sensory nerve action potential amplitude from digit 3; MedDig1AMP  = 
median sensory nerve action potential amplitude from digit 1; RadDig1AMP = radial sensory nerve 
action potential amplitude from digit 1.  
MedDig3AMP and MedDig1AMP share a recording electrode position, MedDig1AMP and 
RadDig1AMP share a stimulating electrode position, and MedDig3AMP and RadDig1AMP share 
neither. 
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Table 3. Linear mixed models (multilevel analysis) with skin temperature as independent variable. 
Dependent variable 
Regression 
coefficient 
p 
Variance 
explained (%) 
MedDig3AMP -0.09 0.894  
MedDig3CV 1.26 <0.001* 42.8 
MedDig1AMP -0.38 0.568  
MedDig1CV 1.61 <0.001* 40.3 
RadDig1AMP 0.27 0.397  
RadDig1CV 1.44 <0.001* 48.4 
MedCMAPamp -0.34 0.239  
MedCV 0.43 0.097  
MedFwmin -0.11 0.013* 18.6 
 
MedDig3AMP = median sensory nerve action potential amplitude from digit 3 (µV); MedDig3CV = 
median-digit 3 sensory nerve action potential conduction velocity (m/s); MedDig1AMP = median 
sensory nerve action potential amplitude from digit 1 (µV); MedDig1CV= median-digit 1 sensory 
nerve action potential conduction velocity (m/s); RadDig1AMP = radial sensory nerve action 
potential amplitude from digit 1 (µV); RadDig1CV = radial-digit 1 sensory nerve action potential 
conduction velocity (m/s); MedCMAPamp = median compound motor action potential amplitude 
(mV); MedCV = median nerve motor forearm velocity (m/s);  MedFwmin =  median nerve minimum 
F-wave latency (ms); * ≤ 0.05. 
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Supplementary methods: 
The sensory NCS were performed using a reusable plastic block recording electrode with 
removable felt pads placed on stainless steel plates (18 mm by 6 mm) whose centres were 20 mm 
apart; the stimulation was given through ring electrodes, placed approximately 2 cm apart, with the 
active electrode placed proximally with respect to the reference. For the motor NCS, a bipolar nerve 
stimulation electrode with 6-mm diameter felt pads and an interelectrode separation of 25 mm was 
used; recording was performed with the same surface electrode used in the sensory study. The ground 
was a disposable electrode with silver/silver chloride recording surfaces, self-adhesive and self-
conductive, that was placed between the stimulating and recording electrodes and was replaced every 
day. Parameters were recorded using a Dantec KeypointTM electromyography (EMG) instrument 
(Natus Medical Incorporate, Pleasanton, CA), with an amplifier gain of 5 mV/div, time sweep of 5 
ms/div, bandpass of 2 Hz to10 KHz; the stimulus frequency was 2 Hz and stimulus duration 0.2 ms. 
For median sensory orthodromic NCS, ring stimulation electrodes were placed around the 
third finger with the cathode placed over the proximal crease and the anode over the most distal; 
recording electrodes were on the midline wrist, between the flexor carpi radialis and the palmaris 
longus tendons. For each measurement, the examiner followed the following sequence: recording of 
SNAP amplitude; adjustment of recording electrode position to ensure maximal response; increase 
of stimulus strength until supramaximal; clearing of the trace; average of 20 supramaximal stimuli; 
recording of the latency and amplitude; measurement of distance (mm) and computer-derived 
estimation of conduction velocity. Importantly, in order not to alter the position of the recording 
electrode, once the location with the largest median-digit 3 SNAP amplitude was obtained, the 
examiner shifted to the median-digit 1 SNAP amplitude study without touching the wrist recording 
electrodes. The stimulating electrodes were placed with the cathode over the proximal thumb crease 
and the anode over the distal crease and the median-digit 1 SNAP measured as per the median-digit 
3 SNAP. For radial sensory orthodromic NCS, the stimulation was given in the thumb and the 
recording electrodes placed over the radial aspect of the wrist. In order to leave the stimulation 
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electrode position unaltered, when shifting from the highest median-digit 1 SNAP amplitude to the 
radial-digit 1 SNAP amplitude, the ring electrodes were not touched (figure 1).  
Motor NCS of the median nerve, including the F-waves, was determined from the Abductor 
Pollicis Brevis (APB) muscles. Traditional bipolar montage was used, in which the active recording 
electrode is placed on the midbelly of APB muscle and the reference distally on the metacarpo-
phalangeal joint of the thumb. The sequence was: recording of compound motor action potential 
(CMAP) amplitude after stimulation at the proximal midwrist; adjustment of recording electrode 
position to ensure maximal response; increase of stimulus strength until supramaximal CMAP 
amplitude and distal latency are obtained; repeating for elbow crease (<10% drop in amplitude 
compared to the CMAP amplitude at the wrist was accepted); measurement of the distance (mm) 
between wrist and elbow and calculation of conduction velocity.  
F-wave studies consisted of applying 20 supramaximal stimuli to the median nerve at the wrist 
keeping the same montage used for the motor NCS. F-waves were defined as compound action 
potentials, clearly separated from the M-wave and the background noise, with variable latencies and 
configurations, evoked intermittently from a muscle by supramaximal electric stimulation to the 
nerve, having a smaller amplitude and longer latency than the M-wave. Latencies were measured to 
the onset of the responses, independent of whether the initial deflections were positive or negative. 
Minimum, mean and maximum latencies and velocities were determined. The mean latency was 
automatically calculated by dividing the sum of all latencies by the number of F-waves recorded in 
each trial. Care was taken in order not to mistake F-waves for A-waves (waves with a high persistence 
and similar waveform and latencies). 
As a general rule, no movement was made of any electrode unless the baseline was not stable 
or if the stimulus artefact disturbed it. In these circumstances, actually very rare, the electrode was 
removed, the skin was dried and the earth electrode attended to. The entire protocol would then be 
repeated, including optimisation of recording electrode position. SNAP and CMAP amplitude was 
calculated from peak to peak. Onset latency was measured to initial baseline deflection. The machine-
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chosen latency was accepted for most responses; occasionally, the recordings gave a poorly defined 
waveform, which required manual latency determination or adjustment. The entire protocol, 
including measurement of the hand temperature, was repeated on the opposite hand for each trial. 
 
 
